New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Xilio Therapeutics, Inc.
XLO
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

43M

Biotechnology

Next Earning date - 13 May 2025

43M

Biotechnology

Next Earning date - 13 May 2025

0.83USD

Shape-0.01 ( -1.13%)
Market Closed (as of Apr 25, 20:00 EDT)
favorite-chart

Relative Strenght

17
favorite-chart

Volume Buzz

-97%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

51%

Quote Panel

Shape
Updated April 26, 2025
1W 1.66 % 1M 13.51 % 3M 14.75 % 1Y -20.34 %

Key Metrics

Shape
  • Market Cap

    42.90M


  • Shares Outstanding

    51.78M


  • Share in Float

    15.84M


  • Dividende

    0


  • Earning Date

    13 May 2025


  • Price Target

    0.8285


  • Average Volume

    3.70M


  • Beta

    -0.219


  • Range

    0.62-1.7


  • Industry

    Biotechnology


  • Website

    https://www.xiliotx.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

XLO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$52M

Shape2939%

2025-Revenue

$0.40

Shape-67%

2025-EPS

$31M

Shape337%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Chardan Capital

initialise

Previous: Not converted

2022-12-21

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.83
vs -0.78

Q2.23

arrow
arrow

N/A

-0.70
vs -0.90

Q3.23

arrow
arrow

N/A

-0.61
vs -0.72

Q4.23

arrow
arrow

N/A

-0.64
vs -0.82

Q1.24

arrow
arrow

N/A

-0.64
vs -0.83

Q2.24

arrow
arrow

N/A

-0.24
vs -0.70

Q3.24

arrow
arrow

N/A

-0.22
vs -0.61

Q4.24

arrow
arrow

N/A

-0.20
vs -0.64

Q1.25

arrow
arrow

+115%

0.09
vs -0.64

Q2.25

arrow
arrow

N/A

-0.20
vs -0.24

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

2.9M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

2.4M  vs NA

Q3.24

arrow
arrow

NA

2.3M  vs NA

Q4.24

arrow
arrow

-41%

1.7M  vs 2.9M

Q1.25

arrow
arrow

NA

23.2M  vs NA

Q2.25

arrow
arrow

+57%

3.7M  vs 2.4M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-25%

-0.25
vs -0.21

Q2.23

arrow
arrow

-29%

-0.29
vs -0.25

Q3.23

arrow
arrow

-32%

-0.32
vs -0.29

Q4.23

arrow
arrow

-48%

-0.48
vs -0.32

Q1.24

arrow
arrow

-67%

-0.67
vs -0.48

Q2.24

arrow
arrow

-42%

-0.42
vs -0.67

Q3.24

arrow
arrow

-67%

-0.67
vs -0.42

Q4.24

arrow
arrow

-74%

-0.74
vs -0.67

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

32

32
vs 28

14%

Q2.23

arrow
arrow

32

32
vs 32

NA

Q3.23

arrow
arrow

31

31
vs 32

-3%

Q4.23

arrow
arrow

33

33
vs 31

6%

Q1.24

arrow
arrow

31

31
vs 33

-6%

Q2.24

arrow
arrow

31

31
vs 31

NA

Q3.24

arrow
arrow

33

33
vs 31

6%

Q4.24

arrow
arrow

35

35
vs 33

6%

Earnings Growth

Latest News